A detailed history of Great West Life Assurance CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 1,289 shares of MDGL stock, worth $444,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,289
Previous 1,289 -0.0%
Holding current value
$444,937
Previous $361,000 24.1%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$193.33 - $291.99 $59,352 - $89,640
307 Added 31.26%
1,289 $361,000
Q4 2023

Feb 13, 2024

SELL
$120.4 - $237.13 $26,608 - $52,405
-221 Reduced 18.37%
982 $226,000
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $102,228 - $158,046
700 Added 139.17%
1,203 $175,000
Q2 2023

Aug 10, 2023

SELL
$203.88 - $312.0 $12,844 - $19,656
-63 Reduced 11.13%
503 $117,000
Q1 2023

May 12, 2023

BUY
$231.06 - $307.08 $5,314 - $7,062
23 Added 4.24%
566 $137,000
Q2 2022

Aug 12, 2022

BUY
$58.04 - $100.2 $31,515 - $54,408
543 New
543 $39,000
Q2 2022

Aug 09, 2022

SELL
$58.04 - $100.2 $31,515 - $54,408
-543 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$97.2 - $137.59 $25,855 - $36,598
-266 Reduced 32.88%
543 $53,000
Q3 2020

Nov 17, 2020

SELL
$99.78 - $124.21 $6.82 Million - $8.49 Million
-68,391 Reduced 98.83%
809 $96,000
Q3 2020

Nov 13, 2020

BUY
$99.78 - $124.21 $6.82 Million - $8.49 Million
68,391 Added 8453.77%
69,200 $8.22 Million
Q2 2020

Aug 17, 2020

BUY
$60.13 - $125.71 $17,197 - $35,953
286 Added 54.68%
809 $91,000
Q4 2019

Feb 11, 2020

BUY
$84.28 - $118.5 $44,078 - $61,975
523 New
523 $47,000
Q3 2019

Oct 25, 2019

SELL
$84.4 - $106.53 $83,134 - $104,932
-985 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$94.77 - $215.54 $34,685 - $78,887
366 Added 59.13%
985 $107,000
Q4 2017

Feb 09, 2018

BUY
$39.35 - $97.37 $24,357 - $60,272
619
619 $57,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.9B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.